Items where Author is "Cairns, John"

Item Type No Grouping

Article

The Innovative Medicines Fund:a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep? (2023) Angelis, Aris; Aggarwal, Ajay; Miners, Alec; Cairns, John; Briggs, Andrew picture_as_pdf

The evolving nature of Health Technology Assessment:a critical appraisal of NICE’s new methods manual. (2023) Angelis, Aris; Harker, Martin; Cairns, John; Seo, Mikyung Kelly; Legood, Rosa; Miners, Alec; Wiseman, Virginia; Chalkidou, Kalipso; Grieve, Richard; Briggs, Andrew picture_as_pdf

Can patients improve the quality of care they receive? Experimental evidence from Senegal. (2022) Kovacs, Roxanne J.; Lagarde, Mylène; Cairns, John picture_as_pdf

What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries. (2018) Maynou, Laia; Cairns, John picture_as_pdf

Disagreement on cancer drug decisions in Europe. Maynou, Laia; Cairns, John picture_as_pdf

Measuring patient trust:comparing measures from a survey and an economic experiment. Kovacs, Roxanne J.; Lagarde, Mylene; Cairns, John description

Overconfident health workers provide lower quality healthcare. Kovacs, Roxanne J.; Lagarde, Mylene; Cairns, John picture_as_pdf

Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Mulhern, Brendan; Bansback, Nick; Brazier, John; Buckingham, Ken; Cairns, John; Devlin, Nancy; Dolan, Paul; Hole, Arne Risa; Kavetsos, Georgios; Longworth, Louise; Rowen, Donna; Tsuchiya, Aki

Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study. Nicod, Elena; Maynou, Laia; Visintin, Erica; Cairns, John

Why do some countries approve a cancer drug and others don't? Maynou-Pujolras, Laia; Cairns, John